OncoGrants / Funding
Biohub Rare As One Network Grants for Rare Sarcomas

Biohub Rare As One Network Grants for Rare Sarcomas

Due Date: 12/15/2026

The Biohub Rare As One Network Grants for Rare Sarcomas provide US$600,000 over three years to help patient-led organisations advance research and treatment development. The sarcoma cohort covers all ages, with particular emphasis on childhood and adolescent subtypes and rare paediatric presentations of sarcomas more commonly diagnosed in adults.

Selected organisations can use the funding to build research partnerships, bring patients and researchers together to set priorities, and develop shared resources such as registries, tissue collections, or research models. An existing therapeutic development programme is not required.

Eligibility Criteria

  • Applicants must be nonprofits with U.S. 501(c)(3) status or equivalent charitable status outside the United States.
  • Patients, parents, families, or others directly affected by the disease must have meaningful decision-making authority within the organisation.
  • The organisation must represent a rare sarcoma or closely related group affecting fewer than 200,000 people in the United States.
  • Applicants must serve a broader affected community and demonstrate a commitment to advancing research.
  • The organisation’s annual budget must average less than US$10 million over two years.
  • Previous recipients of multi-year Rare As One grants are ineligible. Organisations that received only the one-time US$50,000 Cycle 2 award may still apply.

Funding Details

  • Award: US$600,000 in total costs over three years, or US$200,000 per year.
  • Indirect costs: Up to 15% of direct costs, within the total award.
  • Supported activities: Organisational development, research infrastructure, community engagement, and a meeting that brings patients, researchers, and other partners together.

Deadline

  • Full application: December 15, 2026, at 2:00 p.m. PST.
  • Earliest expected decisions: April 2027.
  • Expected grant start: May 1, 2027.

Further Information

Biohub cancer OncoDaily Oncology paediatric sarcoma Patient Advocacy Patient-Led Research Rare As One rare sarcomas